ILIAD BIOTECHNOLOGIES
ILiAD Biotechnologies (ILiAD) is a clinical-stage biotechnology company focused on the prevention and treatment of disease caused by Bordetella Pertussis. ILiAD's lead candidate is BPZE1, a live-attenuated pertussis vaccine that has successfully completed a Phase 1 human clinical trial. ILiAD Biotechnologies is a registered Delaware company founded in 2012.
ILIAD BIOTECHNOLOGIES
Industry:
Biotechnology Clinical Trials Health Care Pharmaceutical
Founded:
2012-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.iliadbio.com
Total Employee:
11+
Status:
Active
Contact:
(917)913-8511
Email Addresses:
[email protected]
Total Funding:
64.99 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Analytics Google Universal Analytics Apache Euro Google Apps For Business Google Maps YouTube
Similar Organizations
Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.
Novavax
Novavax is a clinical-stage biotechnology company focused on the discovery and development of innovative vaccines.
Current Employees Featured
Founder
Investors List
Knott Partners
Knott Partners investment in Series D - ILiAD Biotechnologies
National Institute of Allergy and Infectious Diseases
National Institute of Allergy and Infectious Diseases investment in Grant - ILiAD Biotechnologies
Network-1
Network-1 investment in Venture Round - ILiAD Biotechnologies
JEMS Venture Capital
JEMS Venture Capital investment in Venture Round - ILiAD Biotechnologies
SDS Capital Partners
SDS Capital Partners investment in Venture Round - ILiAD Biotechnologies
Seedlings Life Science Ventures
Seedlings Life Science Ventures investment in Venture Round - ILiAD Biotechnologies
Official Site Inspections
http://www.iliadbio.com Semrush global rank: 5.76 M Semrush visits lastest month: 1.45 K
- Host name: 177.56.180.107.host.secureserver.net
- IP address: 107.180.56.177
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "ILiAD Biotechnologies"
ILiAD Biotechnologies - Crunchbase Company Profile …
Organization. ILiAD Biotechnologies . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. …See details»
ILiAD Biotechnologies, LLC | LinkedIn
ILiAD Biotechnologies is a [Phase 3 ready] clinical-stage biotech company dedicated to the prevention and treatment of human disease caused by Bordetella pertussis and other …See details»
ILiAD Biotechnologies Company Profile | Management and
Www.iliadbio.com ILiAD Biotechnologies Profile and History ILiAD Biotechnologies is a privately held, clinical stage biotechnology company dedicated to the prevention and treatment of …See details»
ILiAD Biotechnologies - PitchBook
Deal Type Date Amount Raised to Date Post-Val Status Stage; 10. Later Stage VC (Series D) 06-Sep-2022: $42.8M: Completed: Clinical Trials - Phase 2: 9. Grant: 04-May-2022See details»
ILiAD Biotechnologies - Craft
ILiAD Biotechnologies $20.55 m in total funding,. See insights on ILiAD Biotechnologies including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
ILiAD Biotechnologies LLC - Drug pipelines, Patents, Clinical trials ...
May 8, 2025 WESTON, Fla.--( BUSINESS WIRE )--ILiAD Biotechnologies, LLC, a biotech company developing BPZE1, the most advanced next generation intranasal pertussis vaccine …See details»
Emmes partners with ILiAD Biotechnologies to Conduct Phase III …
Jun 24, 2024 Emmes Group is a privately held contract research organization (CRO), wholly owned by New Mountain Capital ... ILiAD Biotechnologies, LLC Email: [email protected] …See details»
ILiAD Biotechnologies, LLC Company Overview, Contact Details ...
Jun 25, 2024 ILiAD Biotechnologies, LLC 's official website is iliadbio.com and has social profiles on LinkedIn. What is ILiAD Biotechnologies, LLC 's SIC code NAICS code? ILiAD …See details»
About ILiAD Biotechnologies - PharmiWeb.jobs
Jun 25, 2024 PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.See details»
ILiAD Biotechnologies, LLC
ILiAD Biotechnologies, LLC (ILiAD) is a clinical stage biotechnology company focused on the prevention and treatment of human disease caused by Bordetella Pertussis. ILiAD …See details»
ILiAD Biotechnologies - Overview, News & Similar companies
Oct 18, 2023 ILiAD Biotechnologies Announces Presentation at the 2023 World Vaccine Congress in Barcelona WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC …See details»
ILiAD Biotechnologies Announces Presentation at the World …
Apr 5, 2023 Press Contact: Ken Solovay COO ILiAD Biotechnologies, LLC [email protected] 800.603.3525 Contacts. Press Contact: Ken Solovay COO ILiAD Biotechnologies, LLC …See details»
ILiAD Biotechnologies Announces Planned Collaboration with …
Jun 24, 2024 Emmes Group is a privately held contract research organization (CRO), wholly owned by New Mountain Capital (https://www.newmountaincapital.com). The company is …See details»
ILiAD Biotechnologies, LLC Information - RocketReach
ILiAD Biotechnologies is a [Phase 3 ready] clinical-stage biotech company dedicated to the prevention and treatment of human disease caused by Bordetella pertussis and other …See details»
ILiAD and hVIVO Sign LOI for Pivotal Phase 3 Trial of BPZE1 …
WESTON, Fla., January 27, 2025--ILiAD Biotechnologies, LLC, a biotech company developing BPZE1, the most advanced next generation intranasal pertussis vaccine to protect against …See details»
ILiAD Biotechnologies Announces $42.8M Financing Round to …
Sep 6, 2022 ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most advanced next generation pertussis vaccine, today announced ...See details»
ILiAD Biotechnologies
ILiAD Biotechnologies, LLC; Matt Bross, Director of Office Operations; 1-800-603-3525. [email protected]. Investors; Bill Steinkrauss, CFO; 1-800-603-3525See details»
Executives, investors stick to basics at BIO 2025
17 hours ago Thibaud Portal, the cofounder, chief operating officer, and acting CEO of small interfering RNA (siRNA) drug developer Alys Pharmaceuticals, calls the BIO meetings “speed …See details»
ILiAD Biotechnologies LLC (ILiAD Biotechnologies LLC) - 药物管线_ …
WESTON, Fla.--( BUSINESS WIRE )--ILiAD Biotechnologies, LLC, a biotech company developing BPZE1, the most advanced next generation intranasal pertussis vaccine to protect against …See details»
生物技术公司ILiAD Biotechnologies宣布计划与Emmes Group合 …
Jun 24, 2024 WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC, a late-stage biotech development company dedicated to the prevention of disease caused by Bordetella …See details»